Trinity Biotech PLC (TRIB) Price Prediction & ForecastTRIBTrinity Biotech PLC

Alphio's TRIB stock price prediction model matches the current Trinity Biotech PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.78 (+1.89%). The 1-week path is $10.17 (+5.89%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Trinity Biotech PLC (TRIB) is not a good buy right now due to its declining performance and negative financial indicators. The current price is $9.68, with a year-to-date change of -56.76%. The company has a forward P/E ratio of 4.54, which may seem attractive, but the gross margin has fluctuated significantly, with the latest at 35.21%. Furthermore, the RSI is at 31.19, indicating oversold conditions, but this could also suggest continued downward pressure. The main risk is the net income, which has been consistently negative, with the latest quarterly net income at -$17.48 million, highlighting ongoing financial struggles.

Trinity Biotech PLC (TRIB) last closed at $9.6, gaining +0.00%. These facts feed the 1-day and 1-week TRIB price prediction above.